Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand
Authors:
- Steve MorganSMSteve Morgan
- Gillian HanleyGHGillian Hanley
- Meghan McMahonMMMeghan McMahon
- Morris BarerMBMorris Barer
- 15 August 2007
- journal article
- Published by Longwoods Publishing in Healthcare Policy
- Vol. 3 (1) , 1-20
Abstract
A national formulary has been proposed as a priority element of Canada's National Pharmaceuticals Strategy. We review a variety of formulary-based policies that might be used in conjunction with a national formulary, drawing on the policies and practices of the Pharmaceutical Management Agency of New Zealand. We consider the potential price impact of an actively managed national formulary by conducting a Canada-New Zealand price comparison for equivalent products in the four largest drug classes: statins, angiotensin-coverting enzyme (ACE) inhibitors, selective serotonin reuptake inhibitors (SSRIs) and proton pump inhibitors (PPIs). The results suggest that potential price savings for Canada in these drug classes are on the order of 21% to 79%. Such price differences would translate into billions of dollars in annual savings if applied across Canada, potentially offsetting the costs of the expansion of pharmacare coverage necessary to achieve both equity and efficiency goals in this sector.Keywords
This publication has 18 references indexed in Scilit:
- Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United KingdomHealth Affairs, 2006
- Public Drug Plan Coverage for Children Across Canada: A Portrait of Too Many ColoursHealthcare Policy, 2005
- Health care provider knowledge of drug formulary status in ambulatory care settingsAmerican Journal of Health-System Pharmacy, 2004
- "Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agencyAustralian Health Review, 2004
- The 'NICE' Approach to Technology Assessment: An Economics PerspectiveHealth Care Management Science, 2004
- The Changing Face Of Pharmacy Benefit DesignHealth Affairs, 2004
- Whither Seniors’ Pharmacare: Lessons From (And For) CanadaHealth Affairs, 2003
- Evidence-Based Coverage PolicyHealth Affairs, 2001
- Managing Pharmaceutical Expenditure while Increasing AccessPharmacoEconomics, 1999
- Going for the Gold: The Redistributive Agenda Behind Market-Based Health Care ReformJournal of Health Politics, Policy and Law, 1997